Risk scores: A valid tool for reducing mortality in cardiogenic shock?
作者信息
Palamara Gloria, Aimo Alberto, Tomasoni Daniela
机构信息
Cardiology, ASST Spedali Civili and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
Interdisciplinary Center for Health Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.
出版信息
ESC Heart Fail. 2024 Dec;11(6):3466-3469. doi: 10.1002/ehf2.15040. Epub 2024 Aug 29.
Abstract
摘要
相似文献
1
Risk scores: A valid tool for reducing mortality in cardiogenic shock?风险评分：降低心源性休克死亡率的有效工具？
ESC Heart Fail. 2024 Dec;11(6):3466-3469. doi: 10.1002/ehf2.15040. Epub 2024 Aug 29.
2
External validation and comparison of the CardShock and IABP-SHOCK II risk scores in real-world cardiogenic shock patients.CardShock和IABP-SHOCK II风险评分在真实世界心源性休克患者中的外部验证及比较
Eur Heart J Acute Cardiovasc Care. 2021 Mar 5;10(1):16–24. doi: 10.1177/2048872619895230. Epub 2020 Jan 31.
3
Risk Scores in ST-Segment Elevation Myocardial Infarction Patients with Refractory Cardiogenic Shock and Veno-Arterial Extracorporeal Membrane Oxygenation.伴有难治性心源性休克和静脉-动脉体外膜肺氧合的ST段抬高型心肌梗死患者的风险评分
J Clin Med. 2021 Mar 1;10(5):956. doi: 10.3390/jcm10050956.
4
Comparative Prognostic Accuracy of Risk Prediction Models for Cardiogenic Shock.心原性休克风险预测模型的比较预后准确性。
J Intensive Care Med. 2020 Dec;35(12):1513-1519. doi: 10.1177/0885066619878125. Epub 2019 Oct 14.
5
The CSP (Cardiogenic Shock Prognosis) Score: A Tool for Risk Stratification of Cardiogenic Shock.心源性休克预后（CSP）评分：一种用于心源性休克风险分层的工具。
Front Cardiovasc Med. 2022 Mar 7;9:842056. doi: 10.3389/fcvm.2022.842056. eCollection 2022.
6
Optimized Risk Score to Predict Mortality in Patients With Cardiogenic Shock in the Cardiac Intensive Care Unit.优化的风险评分预测心脏重症监护病房心源性休克患者的死亡率。
J Am Heart Assoc. 2023 Jul 4;12(13):e029232. doi: 10.1161/JAHA.122.029232. Epub 2023 Jun 22.
7
Differential Prognostic Impact of IABP-SHOCK II Scores According to Treatment Strategy in Cardiogenic Shock Complicating Acute Coronary Syndrome: From the RESCUE Registry.根据治疗策略，IABP-SHOCK II评分对急性冠状动脉综合征并发心源性休克的预后影响差异：来自RESCUE注册研究
Medicina (Kaunas). 2024 Jan 20;60(1):183. doi: 10.3390/medicina60010183.
8
The Range of Cardiogenic Shock Survival by Clinical Stage: Data From the Critical Care Cardiology Trials Network Registry.心源性休克临床分期的生存率范围：来自重症心脏病学试验网络登记处的数据。
Crit Care Med. 2021 Aug 1;49(8):1293-1302. doi: 10.1097/CCM.0000000000004948.
9
Hypoalbuminemia is a frequent marker of increased mortality in cardiogenic shock.低蛋白血症是心源性休克患者死亡率升高的一个常见标志物。
PLoS One. 2019 May 16;14(5):e0217006. doi: 10.1371/journal.pone.0217006. eCollection 2019.
10
Blood glucose and lactate levels as early predictive markers in patients presenting with cardiogenic shock: A retrospective cohort study.血糖和乳酸水平作为心源性休克患者的早期预测标志物：一项回顾性队列研究。
PLoS One. 2024 Jul 25;19(7):e0306107. doi: 10.1371/journal.pone.0306107. eCollection 2024.
本文引用的文献
1
Decoding cardiogenic shock: assessing shock index and its variants as prognostic indicators for in-hospital mortality.解码心源性休克：评估休克指数及其变体作为院内死亡率的预后指标。
ESC Heart Fail. 2024 Oct;11(5):3023-3032. doi: 10.1002/ehf2.14853. Epub 2024 Jun 6.
2
Management of cardiogenic shock: a narrative review.心源性休克的管理：一篇叙述性综述。
Ann Intensive Care. 2024 Mar 30;14(1):45. doi: 10.1186/s13613-024-01260-y.
3
Medical therapy of cardiogenic shock: Contemporary use of inotropes and vasopressors.心原性休克的医学治疗：正性肌力药和血管加压药的当代应用。
Eur J Heart Fail. 2024 Feb;26(2):411-431. doi: 10.1002/ejhf.3162. Epub 2024 Feb 23.
4
Optimized Risk Score to Predict Mortality in Patients With Cardiogenic Shock in the Cardiac Intensive Care Unit.优化的风险评分预测心脏重症监护病房心源性休克患者的死亡率。
J Am Heart Assoc. 2023 Jul 4;12(13):e029232. doi: 10.1161/JAHA.122.029232. Epub 2023 Jun 22.
5
Heart failure: an update from the last years and a look at the near future.心力衰竭：近年来的最新进展及对近期前景的展望。
ESC Heart Fail. 2022 Dec;9(6):3667-3693. doi: 10.1002/ehf2.14257.
6
Prognosis of cardiogenic shock secondary to culprit left main coronary artery lesion-related myocardial infarction.罪犯性左主干冠状动脉病变相关心肌梗死所致心原性休克的预后。
ESC Heart Fail. 2023 Feb;10(1):111-120. doi: 10.1002/ehf2.14128. Epub 2022 Sep 24.
7
Fulminant necrotizing eosinophilic myocarditis after COVID-19 vaccination survived with mechanical circulatory support.COVID-19 疫苗接种后暴发性坏死性嗜酸性心肌炎在机械循环支持下得以存活。
ESC Heart Fail. 2022 Aug;9(4):2732-2737. doi: 10.1002/ehf2.13962. Epub 2022 May 26.
8
Early risk stratification in patients with cardiogenic shock irrespective of the underlying cause - the Cardiogenic Shock Score.无论病因如何，对心源性休克患者进行早期风险分层——心源性休克评分。
Eur J Heart Fail. 2022 Apr;24(4):657-667. doi: 10.1002/ejhf.2449. Epub 2022 Feb 14.
9
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC.2021 ESC 急性和慢性心力衰竭诊断和治疗指南：由欧洲心脏病学会（ESC）急性和慢性心力衰竭诊断和治疗工作组制定。特别感谢欧洲心脏病学会心力衰竭协会（HFA）的贡献。
Eur J Heart Fail. 2022 Jan;24(1):4-131. doi: 10.1002/ejhf.2333.
10
Baseline characteristics, management, and predictors of early mortality in cardiogenic shock: insights from the FRENSHOCK registry.心原性休克的基线特征、处理方法和早期死亡率的预测因素：来自 FRENSHOCK 注册研究的见解。
ESC Heart Fail. 2022 Feb;9(1):408-419. doi: 10.1002/ehf2.13734. Epub 2021 Dec 31.
Zotero 插件